Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31791688

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2019 Dec 7
First author
Clamp AR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2019 Dec 7;394(10214):2043-2045. doi: 10.1016/S0140-6736(19)32948-4.
    note
    Source null
    related pmid
    31791687
    relationship
    Comment in
  2. citation
    Lancet. 2020 Sep 12;396(10253):756-757. doi: 10.1016/S0140-6736(20)31176-4.
    note
    Source null
    related pmid
    32919509
    relationship
    Comment in
  3. citation
    Lancet. 2020 Sep 12;396(10253):756. doi: 10.1016/S0140-6736(20)31175-2.
    note
    Source null
    related pmid
    32919510
    relationship
    Comment in

Authors and identifiers

  1. name
    Clamp AR
    type
    Author
  2. name
    James EC
    type
    Author
  3. name
    McNeish IA
    type
    Author
  4. name
    Dean A
    type
    Author
  5. name
    Kim JW
    type
    Author
  6. name
    O'Donnell DM
    type
    Author
  7. name
    Hook J
    type
    Author
  8. name
    Coyle C
    type
    Author
  9. name
    Blagden S
    type
    Author
  10. name
    Brenton JD
    type
    Author
  11. name
    Naik R
    type
    Author
  12. name
    Perren T
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Clamp AR
    type
    Author
  2. name
    James EC
    type
    Author
  3. name
    McNeish IA
    type
    Author
  4. name
    Dean A
    type
    Author
  5. name
    Kim JW
    type
    Author
  6. name
    O'Donnell DM
    type
    Author
  7. name
    Hook J
    type
    Author
  8. name
    Coyle C
    type
    Author
  9. name
    Blagden S
    type
    Author
  10. name
    Brenton JD
    type
    Author
  11. name
    Naik R
    type
    Author
  12. name
    Perren T
    type
    Author
bibliography ids
  1. nci-bib-5c78f5b04b1806fe5ff06c38
book metadata
content sha256
fa648ca1784374221b32754a5db111f0226455b34d73c0c90227cd699c318725
document type
citation
dois
  1. 10.1016/S0140-6736(19)32259-7
electronic publication date
display
2019 Nov 29
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:31791688
immutable id
pubmed:31791688@fa648ca1784374221b32754a5db111f0226455b34d73c0c90227cd699c318725
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10214
name
Lancet (London, England)
nlm unique id
2985213R
pages
2084-2095
volume
394
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2019 Dec 7;394(10214):2043-2045. doi: 10.1016/S0140-6736(19)32948-4.
    note
    Source null
    related pmid
    31791687
    relationship
    Comment in
  2. citation
    Lancet. 2020 Sep 12;396(10253):756-757. doi: 10.1016/S0140-6736(20)31176-4.
    note
    Source null
    related pmid
    32919509
    relationship
    Comment in
  3. citation
    Lancet. 2020 Sep 12;396(10253):756. doi: 10.1016/S0140-6736(20)31175-2.
    note
    Source null
    related pmid
    32919510
    relationship
    Comment in
outcomes validated
false
pmid
31791688
provenance
batch id
4c5003fbb78890e89ae1
provider
NCBI PubMed ESummary
record sha256
cf1027d779d9b5017cc2654a2b7f40003e9a1ebcf2f9f8eb3f37843cef81f920
response sha256
890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
retrieved at
2026-09-09T23:47:48.270700+00:00
publication date
display
2019 Dec 7
precision
day
year
2019
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31791688/
title
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.

Preserved source evidence · Not medical advice